Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOL (S-1, Leucovorin, Oxaliplatin) in Untreated Metastatic Colorectal Cancer
NCT00524706Phase 2Unknown
- Sponsor
- Shizuoka Cancer Center
- Start
- Aug 2007
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of tegafur, folinic acid and oxaliplatin in colorectal cancer (CRC), sponsored by Shizuoka Cancer Center. Status: unknown.
02
Drugs
tegafurfolinic acidoxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00524706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524706.